Real-world safety of deucravacitinib: insights from the Food and Drug Administration Adverse Event Reporting System.
Saved in:
| Title: | Real-world safety of deucravacitinib: insights from the Food and Drug Administration Adverse Event Reporting System. |
|---|---|
| Authors: | Zhao K; Department of Dermatology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Xiao S; Department of Dermatology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Zhao Y; National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Tu C; Department of Dermatology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. tuchen2023@126.com. |
| Source: | International journal of clinical pharmacy [Int J Clin Pharm] 2025 Oct; Vol. 47 (5), pp. 1215-1223. Date of Electronic Publication: 2025 Apr 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2210-7711 |
|---|---|
| DOI: | 10.1007/s11096-025-01896-1 |
